Results 191 to 200 of about 805,503 (353)

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Unlocking potential: innovative "private-non-profit" partnership for empowering children with disabilities in resource-limited settings in Nepal. [PDF]

Front Public Health
Banskota B, Bhusal R, Yadav PK, Baidya JL, Banskota AK.   +4 more
europepmc   +1 more source

Editorial: Management of Intangible Assets Among Non-profit Organizations: Challenges and Peculiarities. [PDF]

Front Psychol, 2021
Benevene P, Barbieri B, Cortini M, Farnese ML, Kong E, Vecina ML.   +5 more
europepmc   +1 more source

Non-Current Assets And Profit After Tax Of Listed Consumer Goods Firm In Nigeria

Gboyega Olopade, Adeniyi Alexander Abu, Olusola Gabriel Oladapo, Sadat Badanga Iyadi, Michael Ayotunde Oladele, Emmanuel Kwaltam Lohfa   +5 more
openalex   +1 more source

Collaboration of Communities and Non-Profit Organizations in Addressing Environmental Problems with African Countries

, 2021
Ovruncsics Muszeros, Kursmecs Girgő Zsult   +1 more
openalex   +2 more sources

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Social Non-profit Bioentrepreneurship: Current Status and Future Impact on Global Health. [PDF]

Front Public Health, 2021
Sadeghi AH, Koldeweij C, Trujillo-de Santiago G, Tannazi M, Hosseinnia N, van Loosbroek O, Manbachi A, Taverne YJHJ, Bogers AJJC, Alvarez MM.   +9 more
europepmc   +1 more source

(Mis)taking social responsibility? Implementing welfare state reform by private and non-profit organizations [PDF]

, 2019
Nicolette van Gestel, Susanne Boch Waldorff, Jean‐Louis Denis   +2 more
openalex   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Oocyte donors' experience and expectations in a non-profit fertility care setting. [PDF]

J Assist Reprod Genet
Li Piani L, Tshilembi A, De Vos M, Buyse E, Ruttens S, Somigliana E, Tournaye H, Blockeel C.   +7 more
europepmc   +1 more source